DS-3078a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DS-3078a, covering 2019-02-12 to 2019-02-12. Get the full timeline:
Most recent: Clinical Trial Update: A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]